JAK2 and gallbladder cancer: Previously, Fu et al. reported that AG490, JAK2 tyrosine kinase inhibitor, suppressed the growth and invasiveness of GBC-SD and SGC-996 gallbladder cancer cells via inhibition of JAK2 and activation p53 [41].